Differential mRNA expression of neuroimmune markers in the hippocampus of infant mice following toluene exposure during brain developmental period

Journal of Applied Toxicology

Volumn 32, Issue 2, 2012, Pages 126-134

  Win Shwe, T T ^a   Kunugita, Naoki ^b   Yoshida, Yasuhiro ^c   Nakajima, Daisuke ^a   Tsukahara, Shinji ^d   Fujimaki, Hidekazu ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d SAITAMA UNIVERSITY   (Japan)

Author keywords

Cytokines; Developmental toxicity; Hippocampus; Mice; Neurotrophins; Toluene

Indexed keywords

ADAPTOR PROTEIN; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONIZED CALCIUM BINDING ADAPTER MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; NERVE GROWTH FACTOR; TOLL LIKE RECEPTOR 4; TOLUENE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HO 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BODY WEIGHT; BRAIN DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EXPOSURE; FEMALE; FETUS; GENE EXPRESSION; GESTATIONAL AGE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOTOXICITY; MALE; MICROGLIA; MOUSE; NEUROIMMUNOLOGY; NEUROTOXICITY; NEWBORN; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PERINATAL PERIOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C3H; NERVE GROWTH FACTORS; NEUROIMMUNOMODULATION; NF-KAPPA B; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RNA, MESSENGER; SOLVENTS; TOLL-LIKE RECEPTOR 4; TOLUENE; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84855252961     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1643     Document Type: Article

References (55)

1. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
2. Allen SJ, Dawbarn D. 2006. Clinical relevance of the neurotrophins and their receptors. Clin. Sci. (Lond.) 110: 175-191.
3. Alleva E, Aloe L, Bigi S. 1993. An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates. Rev. Neurosci. 4: 41-62.
4. Aloe L, Skaper SD, Leon A, Levi-Montalcini R. 1994. Nerve growth factor and autoimmune diseases. Autoimmunity 19: 141-150.
5. Aloe L, Alleva E, Fiore M. 2002. Stress and nerve growth factor: findings in animal models and humans. Pharmacol. Biochem. Behav. 73: 159-166.
6. American Conference of Governmental Industrial Hygienists. 2006. Threshold Limit Values and Biological Exposure Indices Guide. Available from.
7. Barde YA. 1994. Neurotrophins: a family of proteins supporting the survival of neurons. Prog. Clin. Biol. Res. 390: 45-56.
8. Bayer SA, Altman J, Russo RJ, Zhang X. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14: 83-144.
9. Beg AA. 2002. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23: 509-512.
10. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61: 1013-1021.
11. Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM. 2006. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53: 688-695.
12. Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP. 2008. What's so special about the developing immune system? Int. J. Toxicol. 27: 223-254.
13. Chao MV, Rajagopal R, Lee FS. 2006. Neurotrophin signalling in health and disease. Clin. Sci. (Lond.) 110: 167-173.
14. Dietert RR. 2009. Developmental immunotoxicology: focus on health risks. Chem. Res. Toxicol. 22: 17-23.
15. Dietert RR, Dietert JM. 2008. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability. J. Toxicol. Environ. Health B Crit. Rev. 11: 660-680.
16. Dietert RR, Holsapple MP. 2007. Methodologies for developmental immunotoxicity (DIT) testing. Methods 41: 123-131.
17. Dietert RR, Piepenbrink MS. 2006. Perinatal immunotoxicity: why adult exposure assessment fails to predict risk. Environ. Health Perspect. 114: 477-483.
18. Dietert RR, Etzel RA, Chen D, Halonen M, Holladay SD, Jarabek AM, Landreth K, Peden DB, Pinkerton K, Smialowicz RJ, Zoetis T. 2000. Workshop to identify critical windows of exposure for children's health: Immune and Respiratory Systems Work Group summary. Environmental Health Perspectives Supplements 108: S3.
19. Dobbing J. 1971. Undernutrition and the developing brain. The relevance of animal models to the human problem. Bibl. Nutr. Dieta. 17: 35-46.
20. Dumas TC. 2005. Late postnatal maturation of excitatory synaptic transmission permits adult-like expression of hippocampal-dependent behaviors. Hippocampus 15: 562-578.
21. Elkabes S, DiCicco-Bloom EM, Black IB. 1996. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. Neuroscience 16: 2508-2521.
22. Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F, Meinl E. 2005. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159: 12-19.
23. Fiore M, Probert L, Kollias G, Akassoglou K, Alleva E, Aloe L. 1996. Neurobehavioral alterations in developing transgenic mice expressing TNF-alpha in the brain. Brain Behav. Immunol. 10: 126-138.
24. Gelazonia L, Japaridze N, Svanidze I. 2006. Pyramidal cell loss in hippocampus of young rats exposed to toluene. Georgian Med. News 135: 126-128.
25. Giulian D. 1992. Microglia and disease of the nervous system. Curr. Top. Neurol. 12: 23-54.
26. Glezer I, Simard AR, Rivest S. 2007. Neuroprotective role of the innate immune system by microglia. Neuroscience 147: 867-883.
27. Goodlett CR, Mahoney JC, West JR. 1989. Brain growth deficits following a single day of alcohol exposure in the neonatal rat. Alcohol 6: 121-126.
28. Gotohda T, Tokunaga I, Kubo S, Morita K, Kitamura O, Eguchi A. 2000. Effect of toluene inhalation on astrocytes and neurotrophic factor in rat brain. Forensic. Sci. Int. 113: 233-238.
29. Heese K, Hock C, Otten U. 1998. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70: 699-707.
30. Hertz-Picciotto I, Park HY, Dostal M, Kocan A, Trnovec T, Sram R. 2008. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin. Pharmacol. Toxicol. 102: 146-154.
31. Hori H, Ishidao T, Oyabu T, Yamato H, Morimoto Y, Tanaka I. 1999. Effect of simultaneous exposure to methanol and toluene vapor on their metabolites in rats. J. Occup. Health 41: 149-153.
32. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
33. Japan Society for Occupational Health. 1994. Toluene. Indust. Med. 36: 103-110.
34. Kempermann G, Kuhn HG, Gage FH. 1997. Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc. Natl Acad. Sci. USA 94: 10409-10414.
35. Korbo L, Ladefoged O, Lam HR, Ostergaard G, West MJ, Arlien-Søborg P. 1996. Neuronal loss in hippocampus in rats exposed to toluene. Neurotoxicology 17: 359-366.
36. Lafon M, Megret F, Lafage M, Prehaud C. 2006. The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J. Mol. Neurosci. 29: 185-194.
37. Levi-Montalcini R, Aloe L, Alleva E. 1990. A role for nerve growth factor in nervous, endocrine and immune system. Prog. Neurol. Endocrinol. Immunol. 3: 1-10.
38. Marshak-Rothstein A. 2006. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6: 823-835.
39. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335-339.
40. Nakajima D, Tin-Tin-Win-Shwe, Kakeyama M, Fujimaki H, Goto S. 2006. Determination of toluene in brain of freely moving mice using solid-phase microextraction technique. Neurotoxicology 27: 615-618.
41. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173: 3916-3924.
42. Otten U, Gadient RA. 1995. Neurotrophins and cytokines - intermediaries between the immune and nervous systems. Int. J. Devl. Neurosci. 13: 147-151.
43. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M. 2006. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiat. 59: 546-554.
44. Quinn R. 2005. Comparing rat's to human's age: how old is my rat in people years? Nutrition 21: 775-777.
45. Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M. 2007. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9: 1081-1088.
46. Rubartelli A, Lotze MT. 2007. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28: 429-436.
47. Takei Y, Laskey R. 2008. Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease. Trends Mol. Med. 14: 381-388.
48. Terashi H, Nagata K, Satoh Y, Hirata Y, Hatazawa J. 1997. Hippocampal hypoperfusion underlying dementia due to chronic toluene intoxication. Rinsho Shinkeigaku 37: 1010-1013.
49. Toran-Allerand CD, Singh M, Sétáló G Jr. 1999. Novel mechanisms of estrogen action in the brain: new players in an old story. Front. Neuroendocrinol. 20: 97-121.
50. United States Environmental Protection Agency. 1994. Chemical Summary of Toluene. Prepared by the Office of Pollution Prevention and Toxics. EPA 749-F-94-021a.
51. Win-Shwe TT, Yamamoto S, Ahmed S, Kakeyama M, Kobayashi T, Fujimaki H. 2006. Brain cytokine and chemokine mRNA expression in mice induced by intranasal instillation with ultrafine carbon black. Toxicol. Lett. 163: 153-160.
52. Win-Shwe TT, Mitsushima D, Nakajima D, Ahmed S, Yamamoto S, Tsukahara S, Kakeyama M, Goto S, Fujimaki H. 2007a. Toluene induces rapid and reversible rise of hippocampal glutamate and taurine neurotransmitter levels in mice. Toxicol. Lett. 168: 75-82.
53. Win-Shwe TT, Yamamoto S, Nakajima D, Furuyama A, Fukushima A, Ahmed S, Goto S, Fujimaki H. 2007b. Modulation of neurological related allergic reaction in mice exposed to low-level toluene. Toxicol. Appl. Pharmacol. 222: 17-24.
54. Win-Shwe TT, Tsukahara S, Ahmed S, Fukushima A, Yamamoto S, Kakeyama M, Nakajima D, Goto S, Kobayashi T, Fujimaki H. 2007c. Athymic nude mice are insensitive to low-level toluene-induced up-regulation of memory-related gene expressions in the hippocampus. Neurotoxicology 28: 957-964.
55. Win-Shwe TT, Yoshida Y, Kunugita N, Tsukahara S, Fujimaki H. 2010. Does early life toluene exposure alter the expression of NMDA receptor subunits and signal transduction pathway in infant mouse hippocampus? Neurotoxicology 31: 647-653.